A new therapeutic approach for the treatment of sepsis
Open Access
- 31 March 2004
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 62 (3) , 342-345
- https://doi.org/10.1016/j.mehy.2003.11.009
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The effects of bosentan, aminoguanidine and l-canavanine on mesenteric blood flow, spleen and liver in endotoxaemic miceEuropean Journal of Pharmacology, 1999
- Functional characterization of endothelin receptors in hypertensive resistance vesselsJournal Of Hypertension, 1999
- L-canavanine improves organ function and tissue adenosine triphosphate levels in rodent endotoxemia.American Journal of Respiratory and Critical Care Medicine, 1997
- EFFECTS OF L-CANAVANINE, AN INHIBITOR OF INDUCIBLE NITRIC OXIDE SYNTHASE, ON ENDOTOXIN MEDIATED SHOCK IN RATSShock, 1996
- Endothelin production in sepsis and the adult respiratory distress syndromeIntensive Care Medicine, 1996
- Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shockBritish Journal of Pharmacology, 1995
- Lipopolysaccharide Treatment in Vivo Induces Widespread Tissue Expression of Inducible Nitric Oxide Synthase mRNABiochemical and Biophysical Research Communications, 1993
- Pathogenetic Mechanisms of Septic ShockNew England Journal of Medicine, 1993
- Inhibition of nitric oxide synthesis in septic shock: how much is beneficial?The Lancet, 1991
- Endotoxin‐induced impairment of vasopressor and vasodepressor responses in the pithed ratBritish Journal of Pharmacology, 1990